Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study

The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 13; p. 882148
Main Authors Lin, Wenbin, Gan, Wenjia, Feng, Pinning, Zhong, Liangying, Yao, Zhenrong, Chen, Peisong, He, Wanbing, Yu, Nan
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 02.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.Clinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.Seven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.The online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.
AbstractList The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.Clinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.Seven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.The online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.
BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81–0.87), 0.814 (95% CI: 0.77–0.86), and 0.839 (95% CI: 0.79–0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.
Author Zhong, Liangying
Lin, Wenbin
Gan, Wenjia
Chen, Peisong
He, Wanbing
Yu, Nan
Feng, Pinning
Yao, Zhenrong
AuthorAffiliation 2 Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China
3 Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University , Guangzhou , China
4 Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University , Guangzhou , China
1 Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University , Guangzhou , China
AuthorAffiliation_xml – name: 4 Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University , Guangzhou , China
– name: 1 Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University , Guangzhou , China
– name: 3 Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University , Guangzhou , China
– name: 2 Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China
Author_xml – sequence: 1
  givenname: Wenbin
  surname: Lin
  fullname: Lin, Wenbin
– sequence: 2
  givenname: Wenjia
  surname: Gan
  fullname: Gan, Wenjia
– sequence: 3
  givenname: Pinning
  surname: Feng
  fullname: Feng, Pinning
– sequence: 4
  givenname: Liangying
  surname: Zhong
  fullname: Zhong, Liangying
– sequence: 5
  givenname: Zhenrong
  surname: Yao
  fullname: Yao, Zhenrong
– sequence: 6
  givenname: Peisong
  surname: Chen
  fullname: Chen, Peisong
– sequence: 7
  givenname: Wanbing
  surname: He
  fullname: He, Wanbing
– sequence: 8
  givenname: Nan
  surname: Yu
  fullname: Yu, Nan
BookMark eNp9kk1v3CAQhq0qVZOm-QG9cezFW75sQw-VolU_IkXKpT0jDOMskQ0u4ET7C_K3i3dXVdNDuYBm5n2GgfdtdeaDh6p6T_CGMSE_DuBt2FBM6UYISrh4VV2QtuU1ZZKe_XU-r65SesBlcUykFG-qc9ZIwRrCLqrnOz86D2iOYJ3JLng0BQsjGkIsQTfpuEd6tCFliMG7NCHn0ayzA58TenJ5h3b7GWIGn1Z1yW53hZgKM8zLqFfmJ3SN8lOoTRFBRBFyDGmG0u8RUMqL3b-rXg96THB12i-rn1-__Nh-r2_vvt1sr29rwznNNdEDkGZgA2lsN1igDDpijeFMCGmo7LHBVPPeWgMYOtl3jeGmNT3lRHLN2GV1c-TaoB_UaUAVtFOHQIj3SsfszAhKQt9K3suuEZQPvZY9N4RrKrq20XIQhfX5yJqXfgK7Dhf1-AL6MuPdTt2HRyWZwFK0BfDhBIjh1wIpq8klA-OoPYQlKdphLtquk7iUkmOpKS-XIgx_2hCsVj-ogx_U6gd19EPRdP9ojMuH_yi3ceN_lL8BNGzBuQ
CitedBy_id crossref_primary_10_1016_j_surg_2023_04_063
crossref_primary_10_1038_s41440_023_01374_z
crossref_primary_10_1093_jamiaopen_ooae123
crossref_primary_10_1038_s41440_023_01406_8
crossref_primary_10_3389_fendo_2024_1506814
crossref_primary_10_1007_s12553_024_00924_w
Cites_doi 10.1210/jc.2015-4061
10.1161/HYPERTENSIONAHA.120.15026
10.1161/HYPERTENSIONAHA.117.10644
10.1161/HYPERTENSIONAHA.117.10263
10.1016/s0002-9343(70)80021-3
10.1016/j.jacc.2006.07.059
10.1182/blood.V49.3.345.345
10.1016/j.jad.2020.09.027
10.1038/hr.2014.20
10.1161/01.CIR.0000153800.09920.40
10.1210/jc.2011-2885
10.1210/jc.2011-2183
10.1245/s10434-013-2871-3
10.1530/eje-17-0990
10.7326/M20-4873
10.1161/CIRCULATIONAHA.115.001593
10.1507/endocrj.ej11-0133
10.1111/j.1365-2265.2007.02775.x
10.1097/HJH.0000000000002510
10.1503/cmaj.161486
10.1097/SLA.0000000000003200
10.1210/jc.2018-01004
10.1161/CIRCULATIONAHA.117.028201
10.1161/HYPERTENSIONAHA.114.03419
10.1046/j.1523-1755.2003.00929.x
10.1210/er.2018-00139
10.1210/clinem/dgaa177
10.1097/HJH.0000000000001511
10.1038/s41371-018-0112-8
10.1016/j.surg.2018.05.085
10.1210/clinem/dgaa379
10.1007/s00259-020-05140-y
10.1620/tjem.84.339
10.1210/jc.2003-031337
10.1161/01.CIR.0000155621.10213.06
10.1681/ASN.V651459
10.3389/fendo.2020.00023
10.1097/HJH.0000000000001088
10.1016/S2213-8587(21)00210-2
10.1161/CIRCULATIONAHA.118.033597
10.1016/j.kint.2020.06.019
10.1210/en.2017-00651
10.1016/S2213-8587(17)30319-4
10.1161/HYPERTENSIONAHA.121.17444
10.1097/01.hjh.0000217857.20241.0f
10.1016/S2213-8587(17)30367-4
ContentType Journal Article
Copyright Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu.
Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu
Copyright_xml – notice: Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu.
– notice: Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fendo.2022.882148
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_9eb694b975824fba9b4c14a28765a9f8
PMC9380986
10_3389_fendo_2022_882148
GrantInformation_xml – fundername: ;
  grantid: 2021M703708
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c442t-1afe15f3f15d7fde23e71dcc43889c29b0c02a4bddce0e79b75c4c6cb24194a33
IEDL.DBID M48
ISSN 1664-2392
IngestDate Wed Aug 27 01:30:50 EDT 2025
Thu Aug 21 17:54:22 EDT 2025
Fri Jul 11 11:36:58 EDT 2025
Tue Jul 01 04:28:09 EDT 2025
Thu Apr 24 23:07:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-1afe15f3f15d7fde23e71dcc43889c29b0c02a4bddce0e79b75c4c6cb24194a33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Edited by: Alfredo Scillitani, Home for Relief of Suffering (IRCCS), Italy
Reviewed by: Fangli Zhou, Sichuan University, China; Silvia Monticone, University of Turin, Italy
This article was submitted to Adrenal Endocrinology, a section of the journal Frontiers in Endocrinology
These authors have contributed equally to this work and share first authorship
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fendo.2022.882148
PMID 35983513
PQID 2704867790
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_9eb694b975824fba9b4c14a28765a9f8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9380986
proquest_miscellaneous_2704867790
crossref_primary_10_3389_fendo_2022_882148
crossref_citationtrail_10_3389_fendo_2022_882148
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-02
PublicationDateYYYYMMDD 2022-08-02
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-02
  day: 02
PublicationDecade 2020
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Mulatero (B23) 2016; 34
Saiki (B45) 2020; 105
Yamashita (B2) 2018; 36
Na (B27) 2021; 278
Burrello (B30) 2020; 272
Shimamoto (B33) 2014; 37
Kassirer (B35) 1970; 49
Gan (B3) 2019; 33
Williams (B21) 2018; 179
Giacchetti (B43) 2006; 24
Hundemer (B8) 2018; 6
Nishikawa (B19) 2011; 58
Reincke (B42) 2021; 9
Buffolo (B22) 2021; 78
Burrello (B29) 2020; 105
Kline (B17) 2013; 20
Pilz (B12) 2012; 97
Mulatero (B5) 2004; 89
Young (B4) 2007; 66
Nanba (B40) 2018; 103
Taguchi (B41) 2012; 97
Unger (B31) 2020; 75
Chhokar (B11) 2005; 111
Monticone (B9) 2018; 6
Liu (B15) 2018; 71
Ohno (B10) 2018; 71
O'Regan (B46) 1977; 49
Byrd (B1) 2018; 138
Kline (B7) 2017; 189
Mulatero (B20) 2020; 38
Cohen (B25) 2021; 174
Deo (B26) 2015; 132
Liu (B44) 2020; 11
Nanba (B38) 2017; 136
Kuster (B14) 2005; 111
Shioji (B34) 1965; 84
Blasi (B13) 2003; 63
Vaidya (B36) 2018; 39
Mulkerrin (B37) 1995; 6
Rossi (B6) 2006; 48
Funder (B18) 2016; 101
Ruhle (B24) 2019; 165
(B32) 2020; 98
Papp (B28) 2021; 48
Wu (B16) 2018; 159
Fernandes-Rosa (B39) 2014; 64
References_xml – volume: 101
  year: 2016
  ident: B18
  article-title: The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2015-4061
– volume: 75
  year: 2020
  ident: B31
  article-title: International society of hypertension global hypertension practice guidelines
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.120.15026
– volume: 71
  year: 2018
  ident: B15
  article-title: Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.117.10644
– volume: 71
  year: 2018
  ident: B10
  article-title: Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: A multicenter study in Japan
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.117.10263
– volume: 49
  year: 1970
  ident: B35
  article-title: On the pathogenesis of metabolic alkalosis in hyperaldosteronism
  publication-title: Am J Med
  doi: 10.1016/s0002-9343(70)80021-3
– volume: 48
  year: 2006
  ident: B6
  article-title: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.07.059
– volume: 49
  year: 1977
  ident: B46
  article-title: Electrolyte and acid-base disturbances in the management of leukemia
  publication-title: Blood
  doi: 10.1182/blood.V49.3.345.345
– volume: 278
  start-page: 1
  year: 2021
  ident: B27
  article-title: Machine learning-based discrimination of panic disorder from other anxiety disorders
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2020.09.027
– volume: 37
  start-page: 253
  year: 2014
  ident: B33
  article-title: The Japanese society of hypertension guidelines for the management of hypertension (Jsh 2014)
  publication-title: Hypertens Res
  doi: 10.1038/hr.2014.20
– volume: 111
  year: 2005
  ident: B14
  article-title: Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000153800.09920.40
– volume: 97
  year: 2012
  ident: B41
  article-title: Expression and mutations of Kcnj5 mrna in Japanese patients with aldosterone-producing adenomas
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2885
– volume: 97
  year: 2012
  ident: B12
  article-title: Hyperparathyroidism in patients with primary aldosteronism: Cross-sectional and interventional data from the gecoh study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2183
– volume: 20
  year: 2013
  ident: B17
  article-title: Medical or surgical therapy for primary aldosteronism: Post-treatment follow-up as a surrogate measure of comparative outcomes
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-013-2871-3
– volume: 179
  year: 2018
  ident: B21
  article-title: Management of endocrine disease: Diagnosis and management of primary aldosteronism: The endocrine society guideline 2016 revisited
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje-17-0990
– volume: 174
  year: 2021
  ident: B25
  article-title: Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans : A retrospective cohort study
  publication-title: Ann Intern Med
  doi: 10.7326/M20-4873
– volume: 132
  year: 2015
  ident: B26
  article-title: Machine learning in medicine
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.115.001593
– volume: 58
  year: 2011
  ident: B19
  article-title: Guidelines for the diagnosis and treatment of primary aldosteronism–the Japan endocrine society 2009
  publication-title: Endocr J
  doi: 10.1507/endocrj.ej11-0133
– volume: 66
  year: 2007
  ident: B4
  article-title: Primary aldosteronism: Renaissance of a syndrome
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2007.02775.x
– volume: 38
  year: 2020
  ident: B20
  article-title: Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the working group on endocrine hypertension of the European society of hypertension
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000002510
– volume: 189
  year: 2017
  ident: B7
  article-title: Primary aldosteronism: A common cause of resistant hypertension
  publication-title: CMAJ
  doi: 10.1503/cmaj.161486
– volume: 272
  year: 2020
  ident: B30
  article-title: The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000003200
– volume: 103
  year: 2018
  ident: B40
  article-title: Targeted molecular characterization of aldosterone-producing adenomas in white americans
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-01004
– volume: 136
  year: 2017
  ident: B38
  article-title: Age-related autonomous aldosteronism
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.117.028201
– volume: 64
  year: 2014
  ident: B39
  article-title: Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.03419
– volume: 63
  year: 2003
  ident: B13
  article-title: Aldosterone/Salt induces renal inflammation and fibrosis in hypertensive rats
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00929.x
– volume: 39
  year: 2018
  ident: B36
  article-title: The expanding spectrum of primary aldosteronism: Implications for diagnosis, pathogenesis, and treatment
  publication-title: Endocr Rev
  doi: 10.1210/er.2018-00139
– volume: 105
  year: 2020
  ident: B45
  article-title: Diabetes mellitus itself increases cardio-cerebrovascular risk and renal complications in primary aldosteronism
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaa177
– volume: 36
  year: 2018
  ident: B2
  article-title: Screening of primary aldosteronism by clinical features and daily laboratory tests: Combination of urine ph, sex, and serum K
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000001511
– volume: 33
  start-page: 57
  year: 2019
  ident: B3
  article-title: High efficiency of the aldosterone-to-Renin ratio in precisely detecting primary aldosteronism
  publication-title: J Hum Hypertens
  doi: 10.1038/s41371-018-0112-8
– volume: 165
  year: 2019
  ident: B24
  article-title: Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives
  publication-title: Surgery
  doi: 10.1016/j.surg.2018.05.085
– volume: 105
  year: 2020
  ident: B29
  article-title: Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaa379
– volume: 48
  year: 2021
  ident: B28
  article-title: Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-Psma-11 Pet/Mri
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-020-05140-y
– volume: 84
  year: 1965
  ident: B34
  article-title: Effects of salt restriction, spironolactone, and ammonium chloride on acid-base relations in a case of primary aldosteronism
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.84.339
– volume: 89
  year: 2004
  ident: B5
  article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031337
– volume: 111
  year: 2005
  ident: B11
  article-title: Hyperparathyroidism and the calcium paradox of aldosteronism
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000155621.10213.06
– volume: 6
  year: 1995
  ident: B37
  article-title: Aldosterone responses to hyperkalemia in healthy elderly humans
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V651459
– volume: 11
  year: 2020
  ident: B44
  article-title: Higher blood urea nitrogen and urinary calcium: New risk factors for diabetes mellitus in primary aldosteronism patients
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2020.00023
– volume: 34
  year: 2016
  ident: B23
  article-title: Guidelines for primary aldosteronism: Uptake by primary care physicians in Europe
  publication-title: J Hypertens
  doi: 10.1097/HJH.0000000000001088
– volume: 9
  year: 2021
  ident: B42
  article-title: Diagnosis and treatment of primary aldosteronism
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(21)00210-2
– volume: 138
  year: 2018
  ident: B1
  article-title: Primary aldosteronism: Practical approach to diagnosis and management
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.033597
– volume: 98
  start-page: S1
  year: 2020
  ident: B32
  article-title: KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2020.06.019
– volume: 159
  year: 2018
  ident: B16
  article-title: Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma
  publication-title: Endocrinology
  doi: 10.1210/en.2017-00651
– volume: 6
  start-page: 41
  year: 2018
  ident: B9
  article-title: Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(17)30319-4
– volume: 78
  year: 2021
  ident: B22
  article-title: Clinical score and machine learning-based model to predict diagnosis of primary aldosteronism in arterial hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.121.17444
– volume: 24
  year: 2006
  ident: B43
  article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: Need for a standardized protocol
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000217857.20241.0f
– volume: 6
  year: 2018
  ident: B8
  article-title: Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(17)30367-4
SSID ssj0000401998
Score 2.3313344
Snippet The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to...
BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 882148
SubjectTerms Endocrinology
hypertension
online prediction model
primary aldosteronism
primary care
risk factors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yB_EiPnF9EcGTUGzTtGm8qbgsgp4UvIUkTVFYW2kr_gT_tjNpd2kvevGaR5tkJpmZZOYbQs6dSFgGx35gOVg6sBML2FJCBGDfshzEZxoZvNB_eEznz_z-JXkZpPpCn7AOHrhbuEvpTCq5kaDXMl4YLQ23Edeg6KeJloUP8wWZNzCm_BkMZgMYEt0zJlhh8rJwZY7BfowBb7AI8_0MBJHH6x8pmWMXyYHMmW2RzV5ZpNfdILfJmit3yPpD_xy-S747oFD6UWMRLjH1mW0oaKJQ6HEkqF7kGMiBGLjNO30raQ-l2lC8g6WvYIjW3o0dekMtJtR2DXxzldnril7T9qsKcJCuprVr62oZoEk9PO0eeZ7dPd3Ogz6zApCEszaIdOGipIiLKMlFkTsWOxHl1vI4y6Rl0oQ2ZJqbHOYfOiGNSCy3qTUg7yXXcbxPJmVVugNCJZdWpzwLM865iNMMFEohNMt1bHQkwikJl8usbA87jtkvFgrMD6SM8pRRSBnVUWZKLlZd-rX6rfEN0m7VEOGyfQEwkeqZSP3FRFNytqS8gu2Fbya6dNVno5jwmIRCwkTEiCVGfxzXlG-vHqhbxlkos_TwP4Z4RDZw1t73kB2TSVt_uhPQh1pz6ln_B2PYDMo
  priority: 102
  providerName: Directory of Open Access Journals
Title Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study
URI https://www.proquest.com/docview/2704867790
https://pubmed.ncbi.nlm.nih.gov/PMC9380986
https://doaj.org/article/9eb694b975824fba9b4c14a28765a9f8
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9UwFA5zA_Fl6FTcdCODPQnVJk2TRhCZ4jYG1ycv3LeQpKkb3LXadqh_wf5tz8nNvVgY4ksf0jZt8vX0nC8_vkPISVAlr-C3n3kBTAcssQGTUioDfstrcJ-SORzQn32RF3NxuSgXW2Sd3ip14HAvtcN8UvN--ebXj98fwODfI-MEf_u2CW2N-_g4B9g5xPcPyA44JoUJDWYp2o8_ZuASOmbHZVKKjENosJrnvL-WiaeKgv6TKHS6hvIvp3T2mOymaJKeruB_QrZCu0ceztJ8-VNyt1ISpd97LEIMaEx9QyFUhcIoNEHtssadHiiSO9zQ65YmrdWB4iAtvQKm2sd17nA3nMWM22GAOjepv97RUzr-7DJ8ydDTPox9t97BSaN-7TMyP_v89dNFllIvAGaCjxmzTWBlUzSsrFVTB14ExWrvRVFV2nPtcp9zK1wN7c-D0k6VXnjpHfS7FrYonpPttmvDC0K10N5KUeWVEEIVsoKIUynLa1s4y1S-T_J1NxufdMkxPcbSAD9BZExExiAyZoXMPnm9uSX11b8u_ojYbS5EPe1Y0PXfTDJPo4OTWjgN7ImLxlnthGfCAp2UpdUNVHK8Rt6A_eGkim1DdzsYrqJoodLQEDX5JCZPnJ5pr6-ikrcuqlxX8uA_an9JHmGj4tpD_opsj_1tOIR4aHRHcRwBjucLdhS_-D95Vg4J
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Online+prediction+model+for+primary+aldosteronism+in+patients+with+hypertension+in+Chinese+population%3A+A+two-center+retrospective+study&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Lin%2C+Wenbin&rft.au=Gan%2C+Wenjia&rft.au=Feng%2C+Pinning&rft.au=Zhong%2C+Liangying&rft.date=2022-08-02&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=13&rft.spage=882148&rft_id=info:doi/10.3389%2Ffendo.2022.882148&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon